Alteration of α-tocopherol-associated protein (TAP) expression in human breast epithelial cells during breast cancer development.
Ka-Wai Tam, Chi-Tang Ho, Wen-Jui Lee, Shih-Hsin Tu, Ching-Shui Huang, Ching-Shyang Chen, Chia-Hwa Lee, Chih-Hsiung Wu, Yuan-Soon Ho
Index: Food Chem. 138(2-3) , 1015-21, (2013)
Full Text: HTML
Abstract
Breast cancer is the most common malignancy among women and has an age-specific incidence profile. Over the last decade, many studies have demonstrated the anticancer activity of α-tocopherol, the main and most active form of natural vitamin E. α-Tocopherol-associated protein (TAP) was found to be one of the major α-tocopherol binding proteins in human serum and in liver, brain, and prostate tissues. In this study, we found that reduced TAP expression was significantly correlated with Her2/neu receptor expression, breast cancer stage and nodal stage in paired normal and cancerous breast tissue samples from 93 patients using real-time PCR analysis. A cell viability assay showed that α-tocopheryl succinate (α-TOS), a synthetic derivative of α-tocopherol, enhanced the cells' sensitivity to doxorubicin and resulted in a reduction in cell viability in breast cancers. Taken together, these data suggest that the use of vitamin E or its analogue as a dietary supplement may be beneficial for the treatment of cancer.Copyright © 2012 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2010-01-01
[Chem. Res. Toxicol. 23 , 171-83, (2010)]
2013-01-01
[PLoS ONE 8(1) , e47448, (2013)]
2013-02-15
[Carbohydr. Polym. 92(2) , 1915-20, (2013)]
2015-08-01
[AAPS PharmSciTech 16 , 846-54, (2015)]
2015-03-01
[Pharm. Dev. Technol. 20(2) , 211-8, (2015)]